Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World Study

BACKGROUND: Most patients with small-cell lung cancer (SCLC) have extensive-stage (ES) disease with a poor prognosis. Immunotherapy has shown good therapeutic effects in the treatment of ES-SCLC. We performed a real-world retrospective study to evaluate the safety and efficacy of PD-L1 inhibitors pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Jingjing, Kalyani, Farhin Shaheed, Shen, Qian, Yang, Guangdie, Cheng, Tianli, Liu, Li, Zhou, Jianya, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529407/
https://www.ncbi.nlm.nih.gov/pubmed/36199793
http://dx.doi.org/10.1155/2022/3645489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529407/
https://www.ncbi.nlm.nih.gov/pubmed/36199793
http://dx.doi.org/10.1155/2022/3645489

Ejemplares similares